drugset / Trial / NCT01769066
Clinical Value of Sequential Gefitinib With Pemetrexed/Platinum for Advanced NSCLC
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of this study is to explore the Clinical Value of Sequential Gefitinib With Pemetrexed/Platinum compare with Pemetrexed/Platinum for Advanced NSCLC.
Timeline
- Start
- 2009-12
- Primary completion
- 2014-02
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gefitinib | Small molecule | 250 mg | Oral |
| Background | CAP | Unknown | 5 unknown | Intravenous |
| Background | DDP | Unknown | 75 mg/m2 | Intravenous |
| Background | Pemetrexed | Small molecule | 500 mg/m2 | Intravenous |